Clinical course of infectious intracranial aneurysm undergoing antibiotic treatment

Cory J. Rice, Sung-Min Cho, Robert J. Marquardt, Lucy Q. Zhang, Jean Khoury, Julian Hardman, Dolora Wisco, M. Shazam Hussain, Ken Uchino

Research output: Contribution to journalArticle

Abstract

Introduction: Infectious intracranial aneurysm (IIA, or mycotic aneurysm) is a cerebrovascular complication of infective endocarditis. We aimed to describe the clinical course of IIAs during antibiotic treatment. Methods: We reviewed medical records of persons with infective endocarditis who underwent cerebral angiography at a single tertiary referral center from 2011 to 2016. Aneurysms were followed with subsequent angiography for unfavorable outcome (growth, rupture, no change, or new IIA formation) or favorable outcome (regression or resolution) until endovascular therapy, aneurysm resolution, or end of observation. Results: Of 618 patients included, 40 (6.5%) had 43 IIAs. Eighteen (42%) aneurysms underwent initial endovascular treatment. Twenty-five unruptured aneurysms were followed for a median 18 antibiotic days after IIA discovery (interquartile range [IQR] 4–32). Eleven (44%) aneurysms had unfavorable outcome (1 rupture, 2 new IIA formation, 6 enlargement, and 2 no change) at median 21 days (IQR 5–32). Favorable angiographic outcome was seen in 7 (28%) patients (6 resolution, 1 regression) at median 36 days (IQR 24–41). Seven aneurysms had no angiographic reevaluations but showed no evidence of rupture during clinical follow-up for median 4 days (IQR 3–12) until hospital discharge. Saccular morphology was associated with unfavorable aneurysmal outcome (p = 0.013). Longer duration of antibiotic exposure prior to IIA discovery was associated with favorable aneurysmal outcome (p = 0.046). Conclusion: IIAs represent a dynamic disease. Only a quarter of IIAs resolve with antibiotics alone. Saccular aneurysmal morphology might predict unfavorable aneurysmal outcome. IIA found after longer antibiotic therapy has higher likelihood of resolution or regression on antibiotic treatment.

Original languageEnglish (US)
Pages (from-to)50-55
Number of pages6
JournalJournal of the Neurological Sciences
Volume403
DOIs
StatePublished - Aug 15 2019

Fingerprint

Intracranial Aneurysm
Aneurysm
Anti-Bacterial Agents
Rupture
Endocarditis
Therapeutics
Infected Aneurysm
Cerebral Angiography
Tertiary Care Centers
Medical Records
Angiography
Observation
Growth

Keywords

  • Angiogram
  • Antibiotics
  • Infectious intracranial aneurysm

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Clinical course of infectious intracranial aneurysm undergoing antibiotic treatment. / Rice, Cory J.; Cho, Sung-Min; Marquardt, Robert J.; Zhang, Lucy Q.; Khoury, Jean; Hardman, Julian; Wisco, Dolora; Hussain, M. Shazam; Uchino, Ken.

In: Journal of the Neurological Sciences, Vol. 403, 15.08.2019, p. 50-55.

Research output: Contribution to journalArticle

Rice, CJ, Cho, S-M, Marquardt, RJ, Zhang, LQ, Khoury, J, Hardman, J, Wisco, D, Hussain, MS & Uchino, K 2019, 'Clinical course of infectious intracranial aneurysm undergoing antibiotic treatment', Journal of the Neurological Sciences, vol. 403, pp. 50-55. https://doi.org/10.1016/j.jns.2019.06.004
Rice, Cory J. ; Cho, Sung-Min ; Marquardt, Robert J. ; Zhang, Lucy Q. ; Khoury, Jean ; Hardman, Julian ; Wisco, Dolora ; Hussain, M. Shazam ; Uchino, Ken. / Clinical course of infectious intracranial aneurysm undergoing antibiotic treatment. In: Journal of the Neurological Sciences. 2019 ; Vol. 403. pp. 50-55.
@article{85ee5e56cce5465099a2b328ee4d2c0d,
title = "Clinical course of infectious intracranial aneurysm undergoing antibiotic treatment",
abstract = "Introduction: Infectious intracranial aneurysm (IIA, or mycotic aneurysm) is a cerebrovascular complication of infective endocarditis. We aimed to describe the clinical course of IIAs during antibiotic treatment. Methods: We reviewed medical records of persons with infective endocarditis who underwent cerebral angiography at a single tertiary referral center from 2011 to 2016. Aneurysms were followed with subsequent angiography for unfavorable outcome (growth, rupture, no change, or new IIA formation) or favorable outcome (regression or resolution) until endovascular therapy, aneurysm resolution, or end of observation. Results: Of 618 patients included, 40 (6.5{\%}) had 43 IIAs. Eighteen (42{\%}) aneurysms underwent initial endovascular treatment. Twenty-five unruptured aneurysms were followed for a median 18 antibiotic days after IIA discovery (interquartile range [IQR] 4–32). Eleven (44{\%}) aneurysms had unfavorable outcome (1 rupture, 2 new IIA formation, 6 enlargement, and 2 no change) at median 21 days (IQR 5–32). Favorable angiographic outcome was seen in 7 (28{\%}) patients (6 resolution, 1 regression) at median 36 days (IQR 24–41). Seven aneurysms had no angiographic reevaluations but showed no evidence of rupture during clinical follow-up for median 4 days (IQR 3–12) until hospital discharge. Saccular morphology was associated with unfavorable aneurysmal outcome (p = 0.013). Longer duration of antibiotic exposure prior to IIA discovery was associated with favorable aneurysmal outcome (p = 0.046). Conclusion: IIAs represent a dynamic disease. Only a quarter of IIAs resolve with antibiotics alone. Saccular aneurysmal morphology might predict unfavorable aneurysmal outcome. IIA found after longer antibiotic therapy has higher likelihood of resolution or regression on antibiotic treatment.",
keywords = "Angiogram, Antibiotics, Infectious intracranial aneurysm",
author = "Rice, {Cory J.} and Sung-Min Cho and Marquardt, {Robert J.} and Zhang, {Lucy Q.} and Jean Khoury and Julian Hardman and Dolora Wisco and Hussain, {M. Shazam} and Ken Uchino",
year = "2019",
month = "8",
day = "15",
doi = "10.1016/j.jns.2019.06.004",
language = "English (US)",
volume = "403",
pages = "50--55",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Clinical course of infectious intracranial aneurysm undergoing antibiotic treatment

AU - Rice, Cory J.

AU - Cho, Sung-Min

AU - Marquardt, Robert J.

AU - Zhang, Lucy Q.

AU - Khoury, Jean

AU - Hardman, Julian

AU - Wisco, Dolora

AU - Hussain, M. Shazam

AU - Uchino, Ken

PY - 2019/8/15

Y1 - 2019/8/15

N2 - Introduction: Infectious intracranial aneurysm (IIA, or mycotic aneurysm) is a cerebrovascular complication of infective endocarditis. We aimed to describe the clinical course of IIAs during antibiotic treatment. Methods: We reviewed medical records of persons with infective endocarditis who underwent cerebral angiography at a single tertiary referral center from 2011 to 2016. Aneurysms were followed with subsequent angiography for unfavorable outcome (growth, rupture, no change, or new IIA formation) or favorable outcome (regression or resolution) until endovascular therapy, aneurysm resolution, or end of observation. Results: Of 618 patients included, 40 (6.5%) had 43 IIAs. Eighteen (42%) aneurysms underwent initial endovascular treatment. Twenty-five unruptured aneurysms were followed for a median 18 antibiotic days after IIA discovery (interquartile range [IQR] 4–32). Eleven (44%) aneurysms had unfavorable outcome (1 rupture, 2 new IIA formation, 6 enlargement, and 2 no change) at median 21 days (IQR 5–32). Favorable angiographic outcome was seen in 7 (28%) patients (6 resolution, 1 regression) at median 36 days (IQR 24–41). Seven aneurysms had no angiographic reevaluations but showed no evidence of rupture during clinical follow-up for median 4 days (IQR 3–12) until hospital discharge. Saccular morphology was associated with unfavorable aneurysmal outcome (p = 0.013). Longer duration of antibiotic exposure prior to IIA discovery was associated with favorable aneurysmal outcome (p = 0.046). Conclusion: IIAs represent a dynamic disease. Only a quarter of IIAs resolve with antibiotics alone. Saccular aneurysmal morphology might predict unfavorable aneurysmal outcome. IIA found after longer antibiotic therapy has higher likelihood of resolution or regression on antibiotic treatment.

AB - Introduction: Infectious intracranial aneurysm (IIA, or mycotic aneurysm) is a cerebrovascular complication of infective endocarditis. We aimed to describe the clinical course of IIAs during antibiotic treatment. Methods: We reviewed medical records of persons with infective endocarditis who underwent cerebral angiography at a single tertiary referral center from 2011 to 2016. Aneurysms were followed with subsequent angiography for unfavorable outcome (growth, rupture, no change, or new IIA formation) or favorable outcome (regression or resolution) until endovascular therapy, aneurysm resolution, or end of observation. Results: Of 618 patients included, 40 (6.5%) had 43 IIAs. Eighteen (42%) aneurysms underwent initial endovascular treatment. Twenty-five unruptured aneurysms were followed for a median 18 antibiotic days after IIA discovery (interquartile range [IQR] 4–32). Eleven (44%) aneurysms had unfavorable outcome (1 rupture, 2 new IIA formation, 6 enlargement, and 2 no change) at median 21 days (IQR 5–32). Favorable angiographic outcome was seen in 7 (28%) patients (6 resolution, 1 regression) at median 36 days (IQR 24–41). Seven aneurysms had no angiographic reevaluations but showed no evidence of rupture during clinical follow-up for median 4 days (IQR 3–12) until hospital discharge. Saccular morphology was associated with unfavorable aneurysmal outcome (p = 0.013). Longer duration of antibiotic exposure prior to IIA discovery was associated with favorable aneurysmal outcome (p = 0.046). Conclusion: IIAs represent a dynamic disease. Only a quarter of IIAs resolve with antibiotics alone. Saccular aneurysmal morphology might predict unfavorable aneurysmal outcome. IIA found after longer antibiotic therapy has higher likelihood of resolution or regression on antibiotic treatment.

KW - Angiogram

KW - Antibiotics

KW - Infectious intracranial aneurysm

UR - http://www.scopus.com/inward/record.url?scp=85067307047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067307047&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2019.06.004

DO - 10.1016/j.jns.2019.06.004

M3 - Article

C2 - 31220742

AN - SCOPUS:85067307047

VL - 403

SP - 50

EP - 55

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -